• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与星形细胞瘤恶性转化相关的危险因素:竞争风险回归分析

Risk Factors Associated with Malignant Transformation of Astrocytoma: Competing Risk Regression Analysis.

作者信息

Tunthanathip Thara, Sangkhathat Surasak, Kanjanapradit Kanet

机构信息

Division of Neurosurgery, Department of Surgery, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand.

Department of Surgery, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand.

出版信息

Asian J Neurosurg. 2022 Jun 1;17(1):3-10. doi: 10.1055/s-0042-1748789. eCollection 2022 Mar.

DOI:10.1055/s-0042-1748789
PMID:35873847
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9298577/
Abstract

Malignant transformation (MT) of low-grade astrocytoma (LGA) triggers a poor prognosis in benign tumors. Currently, factors associated with MT of LGA have been inconclusive. The present study aims to explore the risk factors predicting LGA progressively differentiated to malignant astrocytoma.  The study design was a retrospective cohort study of medical record reviews of patients with LGA. Using the Fire and Gray method, the competing risk regression analysis was performed to identify factors associated with MT, using both univariate and multivariable analyses. Hence, the survival curves of the cumulative incidence of MT of each covariate were constructed following the final model.  Ninety patients with LGA were included in the analysis, and MT was observed in 14.4% of cases in the present study. For MT, 53.8% of patients with MT transformed to glioblastoma, while 46.2% differentiated to anaplastic astrocytoma. Factors associated with MT included supratentorial tumor (subdistribution hazard ratio [SHR] 4.54, 95% confidence interval [CI] 1.08-19.10), midline shift > 1 cm (SHR 8.25, 95% CI 2.18-31.21), and nontotal resection as follows: subtotal resection (SHR 5.35, 95% CI 1.07-26.82), partial resection (SHR 10.90, 95% CI 3.13-37.90), and biopsy (SHR 11.10, 95% CI 2.88-42.52).  MT in patients with LGA significantly changed the natural history of the disease to an unfavorable prognosis. Analysis of patients' clinical characteristics from the present study identified supratentorial LGA, a midline shift more than 1 cm, and extent of resection as risk factors associated with MT. The more extent of resection would significantly help to decrease tumor burden and MT. In addition, future molecular research efforts are warranted to explain the pathogenesis of MT.

摘要

低级别星形细胞瘤(LGA)的恶性转化(MT)会导致良性肿瘤的预后不良。目前,与LGA的MT相关的因素尚无定论。本研究旨在探索预测LGA逐渐分化为恶性星形细胞瘤的危险因素。

研究设计为对LGA患者的病历进行回顾性队列研究。采用Fire和Gray方法,进行竞争风险回归分析以确定与MT相关的因素,同时进行单变量和多变量分析。因此,在最终模型之后构建了每个协变量的MT累积发病率的生存曲线。

90例LGA患者纳入分析,本研究中14.4%的病例观察到MT。对于MT,53.8%的MT患者转化为胶质母细胞瘤,而46.2%分化为间变性星形细胞瘤。与MT相关的因素包括幕上肿瘤(亚分布风险比[SHR] 4.54,95%置信区间[CI] 1.08 - 19.10)、中线移位>1 cm(SHR 8.25,95% CI 2.18 - 31.21)以及非全切除,具体如下:次全切除(SHR 5.35,95% CI 1.07 - 26.82)、部分切除(SHR 10.90,95% CI 3.13 - 37.90)和活检(SHR 11.10,95% CI 2.88 - 42.52)。

LGA患者的MT显著改变了疾病的自然史,使其预后不良。本研究对患者临床特征的分析确定幕上LGA、中线移位超过1 cm以及切除范围是与MT相关的危险因素。切除范围越大将显著有助于降低肿瘤负荷和MT。此外,未来有必要进行分子研究以解释MT的发病机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e143/9298577/c06abc620c57/10-1055-s-0042-1748789-i15921-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e143/9298577/3c596ba52008/10-1055-s-0042-1748789-i15921-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e143/9298577/5f0b00f44b51/10-1055-s-0042-1748789-i15921-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e143/9298577/5bb88ab21282/10-1055-s-0042-1748789-i15921-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e143/9298577/c06abc620c57/10-1055-s-0042-1748789-i15921-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e143/9298577/3c596ba52008/10-1055-s-0042-1748789-i15921-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e143/9298577/5f0b00f44b51/10-1055-s-0042-1748789-i15921-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e143/9298577/5bb88ab21282/10-1055-s-0042-1748789-i15921-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e143/9298577/c06abc620c57/10-1055-s-0042-1748789-i15921-4.jpg

相似文献

1
Risk Factors Associated with Malignant Transformation of Astrocytoma: Competing Risk Regression Analysis.与星形细胞瘤恶性转化相关的危险因素:竞争风险回归分析
Asian J Neurosurg. 2022 Jun 1;17(1):3-10. doi: 10.1055/s-0042-1748789. eCollection 2022 Mar.
2
Risk Factors Associated with Malignant Transformation of Astrocytoma: Competing Risk Regression Analysis.与星形细胞瘤恶性转化相关的危险因素:竞争风险回归分析
Asian J Neurosurg. 2021 Dec 18;16(4):777-784. doi: 10.4103/ajns.ajns_159_21. eCollection 2021 Oct-Dec.
3
Malignant transformation in low-grade astrocytoma for long-term monitoring.低度星形细胞瘤的恶性转化需要长期监测。
J Cancer Res Ther. 2022 Oct-Dec;18(6):1616-1622. doi: 10.4103/jcrt.JCRT_1469_20.
4
Molecular Landscape for Malignant Transformation in Diffuse Astrocytoma.弥漫性星形细胞瘤恶性转化的分子图谱
Glob Med Genet. 2021 Sep;8(3):116-122. doi: 10.1055/s-0041-1731069. Epub 2021 Jun 22.
5
Clinical and molecular characteristics of malignant transformation of low-grade glioma in children.儿童低级别胶质瘤恶性转化的临床及分子特征
J Clin Oncol. 2007 Feb 20;25(6):682-9. doi: 10.1200/JCO.2006.06.8213.
6
Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma.血管内皮生长因子表达和血管密度作为低级别星形细胞瘤患者生存的预后标志物。
J Neurosurg. 1998 Mar;88(3):513-20. doi: 10.3171/jns.1998.88.3.0513.
7
Malignant Transformation of Molecularly Classified Adult Low-Grade Glioma.分子分类的成人低级别胶质瘤的恶性转化。
Int J Radiat Oncol Biol Phys. 2019 Dec 1;105(5):1106-1112. doi: 10.1016/j.ijrobp.2019.08.025. Epub 2019 Aug 25.
8
Therapy for supratentorial malignant astrocytomas: survival and possible prognostic factors.幕上恶性星形细胞瘤的治疗:生存率及可能的预后因素。
J Formos Med Assoc. 1993 Mar;92(3):220-6.
9
Spontaneous malignant transformation of a supratentorial pilocytic astrocytoma.幕上毛细胞型星形细胞瘤的自发性恶性转化
Neurocirugia (Astur). 2010 Jun;21(3):245-52. doi: 10.1016/s1130-1473(10)70084-1.
10
Free survival time of recurrence and malignant transformation and associated factors in patients with supratentorial low-grade gliomas.幕上低级别胶质瘤患者复发和恶变的无进展生存期及相关因素
J Med Assoc Thai. 2013 Dec;96(12):1542-9.

本文引用的文献

1
The clinical characteristics and prognostic factors of multiple lesions in glioblastomas.胶质母细胞瘤多发病灶的临床特征和预后因素。
Clin Neurol Neurosurg. 2020 Aug;195:105891. doi: 10.1016/j.clineuro.2020.105891. Epub 2020 May 7.
2
Prognostic Factors and Nomogram Predicting Survival in Diffuse Astrocytoma.弥漫性星形细胞瘤生存预后因素及列线图预测
J Neurosci Rural Pract. 2020 Jan;11(1):135-143. doi: 10.1055/s-0039-3403446. Epub 2020 Mar 3.
3
Glioblastoma Multiforme Associated with Arteriovenous Malformation: A Case Report and Literature Review.
多形性胶质母细胞瘤合并动静脉畸形:一例报告及文献综述
Ann Indian Acad Neurol. 2020 Jan-Feb;23(1):103-106. doi: 10.4103/aian.AIAN_219_18.
4
Temozolomide for patients with wild-type isocitrate dehydrogenase (IDH) 1 glioblastoma using propensity score matching.替莫唑胺治疗 IDH1 野生型胶质母细胞瘤患者的倾向评分匹配研究。
Clin Neurol Neurosurg. 2020 Apr;191:105712. doi: 10.1016/j.clineuro.2020.105712. Epub 2020 Feb 3.
5
Intracranial WHO grade I meningioma: a competing risk analysis of progression and disease-specific survival.颅内世界卫生组织一级脑膜瘤:进展和疾病特异性生存的竞争风险分析
Acta Neurochir (Wien). 2019 Nov 9. doi: 10.1007/s00701-019-04096-9.
6
Survival trends of grade I, II, and III astrocytoma patients and associated clinical practice patterns between 1999 and 2010: A SEER-based analysis.1999年至2010年间I级、II级和III级星形细胞瘤患者的生存趋势及相关临床实践模式:一项基于监测、流行病学和最终结果(SEER)数据库的分析
Neurooncol Pract. 2016 Mar;3(1):29-38. doi: 10.1093/nop/npv016. Epub 2015 Jul 1.
7
Malignant Transformation of Molecularly Classified Adult Low-Grade Glioma.分子分类的成人低级别胶质瘤的恶性转化。
Int J Radiat Oncol Biol Phys. 2019 Dec 1;105(5):1106-1112. doi: 10.1016/j.ijrobp.2019.08.025. Epub 2019 Aug 25.
8
How definitive treatment affects the rupture rate of unruptured cerebral aneurysms: a competing risk survival analysis.确定性治疗如何影响未破裂脑动脉瘤的破裂率:一项竞争风险生存分析。
J Neurosurg. 2019 Mar 8;132(4):1062-1067. doi: 10.3171/2018.11.JNS181781. Print 2020 Apr 1.
9
Diagnostic Yield and Complication of Frameless Stereotactic Brain Biopsy.无框架立体定向脑活检的诊断率及并发症
J Neurosci Rural Pract. 2019 Jan-Mar;10(1):78-84. doi: 10.4103/jnrp.jnrp_166_18.
10
Risk Factors for Malignant Transformation of Low-Grade Glioma.低级别胶质瘤恶变的危险因素。
Int J Radiat Oncol Biol Phys. 2018 Mar 15;100(4):965-971. doi: 10.1016/j.ijrobp.2017.12.258. Epub 2017 Dec 21.